Back to Research Hub
Viking Therapeutics, Inc.
VKTX
$37.31-0.64 (-1.69%)
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions.
StreetsValue research for Viking Therapeutics, Inc. (VKTX)
Members get the full report for Viking Therapeutics, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.